"Sundowning" and other temporally associated agitation states in dementia patients

Annual Review of Medicine

Volumn 57, Issue , 2006, Pages 499-511

  Bachman, David ^a   Rabins, Peter ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Sleep

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; HYPNOTIC AGENT; MELATONIN; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; PLACEBO; RIVASTIGMINE; ZOLPIDEM;

AGITATION; ALZHEIMER DISEASE; BEHAVIOR DISORDER; CAREGIVER; CIRCADIAN RHYTHM; CLINICAL TRIAL; DEMENTIA; DISEASE EXACERBATION; ENVIRONMENTAL FACTOR; FATIGUE; HUMAN; IRRITABILITY; NONREM SLEEP; PREVALENCE; PRIORITY JOURNAL; REM SLEEP; RESTLESSNESS; REVIEW; SLEEP DISORDER; SOCIAL ISOLATION; SUNDOWNING; SUPRACHIASMATIC NUCLEUS;

CIRCADIAN RHYTHM; DEMENTIA; HUMANS; MENTAL DISORDERS; PSYCHOMOTOR AGITATION;

EID: 32944454301     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.57.071604.141451     Document Type: Review

References (83)

1. Cameron DE. 1941. Studies in senile nocturnal delirium. Psychiatr. Q. 15:47-53
2. Kim P, Louis C, Muralee S, et al. 2005. Sundowning syndrome in the older patient. Clin. Geriatr. 13(4):32-36
3. Volicer L, Harper DG, Manning BC, et al. 2001. Sundowning and circadian rhythms in Alzheimer's disease. Am. J. Psychiatry 158:704-11
4. American Sleep Disorders Association. 1997. The International Classification of Sleep Disorders: Diagnostic and Coding Manual Revised. Rochester, MN: Am. Sleep Disord. Assoc.
5. Yesavage JA, Friedman L, Ancoli-Israel S, et al. 2003. Development of diagnostic criteria for defining sleep disturbance in Alzheimer's disease. J. Geriatr. Psychiatry Neurol. 16:131-39
6. Bliwise DL. 2004. Sleep disorders in Alzheimer's disease and other dementias. Clic. Cornerstone 6(Suppl. 1A):16-28
7. Evans LK. 1987. Sundown syndrome in institutionalized elderly. J. Am. Geriatr. Soc. 35:101-8
8. Cohen-Mansfield J, Watson V, Meade W, et al. 1989. Does sundowning occur in residents of an Alzheimer's unit? Int. J. Geriatr. Psychiatry 35:101-8
9. Friedman L, Kraemer HC, Zarcone V, et al. 1997. Disruptive behavior and actigraphic measures in home-dwelling patients with Alzheimer's disease: preliminary report. J. Geriatr. Psychiatry Neurol. 10:58-62
10. Bliwise DL, Yesavage JA, Tinklenberg JR. 1992. Sundowning and rate of decline in mental function in Alzheimer's disease. Dementia. 3:335-41
11. Exum ME, Phelps BJ, Nabers LE, et al. 1993. Sundown syndrome: Is it reflected in the use of PRN medications for nursing home residents? Gerontologist. 756-61
12. Little JT, Satlin A, Sunderland T, et al. 1995. Sundown syndrome in severely demented patients with probable Alzheimer's disease. J. Geriatr. Psychiatry Neurol. 8(2):103-6
13. Satlin A, Volicer L, Stopa EG. 1995. Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease. Neurobiol. Aging 16:765-71
14. Bliwise DL, Lee KA. 1993. Development of an agitated behavior rating scale for discrete temporal observations. J. Nurs. Meas. 1:115-24
15. Martin J, Marler M, Shochat T, et al. 2000. Circadian rhythms of agitation in institutionalized patients with Alzheimer's disease. Chronobiol. Int. 17(3):405-18
16. Cohen-Mansfield J, Marx MS, Werner P, et al. 1992. Temporal patterns of agitated nursing home residents. Int. Psychogeriatr. 4(2):197-206
17. Martino-Saltzman D, Blasch BB, Morris RD, et al. 1991. Travel behavior of nursing home residents perceived as wanderers and nonwanderers. Gerontol. 31:666-72
18. Burgio LD, Scilley K, Hardin JM, et al. 1994. Studying disruptive vocalization and contextual factors in the nursing home: computer-assisted real-time observation. J. Gerontol. B Psychol. Sci. Soc. Sci. 49(5):P230-239
19. O'Leary PA, Haley WE, Paul PB. 1993. Behavioral assessment in Alzheimer's disease: use of a 24-hr. log. Psychol. Aging 8:139-43
20. Sloane PD, Mitchell CM, Pressier JS, et al. 1998. Environmental correlates of resident agitation in Alzheimer's disease special care units. J. Am. Geriatr. Soc. 46:862-69
21. Kutner NG, Bliwise DL. 2000. Observed agitation and the phenomenon of "sundowning" among SCU residents. In Research and Practice in Alzheimer's Disease, ed. D Holmes, JA Teresi, M Ory, 151-61. New York: Springer
22. Rindlisbacher P, Hopkins RW. 1992. An investigation of the sundowning syndrome. Int. J. Geritar. Psychiatry 7:15-23
23. Devanand DP, Brodkington CD, Moody BJ, et al. 1992. Behavioral syndromes in Alzheimer's disease. Int. Psychogeriatr. 4(Suppl. 2):161-84
24. Gallagher-Thompson D, Brooks JO III, Bliwise D, et al. 1992. The relations among caregiver stress, "sundowning" symptoms, and cognitive decline in Alzheimer's disease. J. Am. Geriatr. Soc. 40:807-10
25. Vitiello MV, Prinz PN. 1990. Sleep/wake patterns and sleep disorders in Alzheimer's disease. In Handbook of Sleep Disorders, ed. MJ Thorpy, pp. 703-18. New York: Marcel Dekker
26. Bliwise DL, Watts RL, Watts N, et al. 1995. Disruptive nocturnal behavior in Parkinson's disease and Alzheimer's disease. J. Geriatr. Psychiatry Neurol. 8:107-10
27. Grace JB, Walker MP, McKeith IG. 2000. A comparison of sleep profiles in patients with dementia with Lewy bodies and Alzheimer's disease. Int. J. Geriatr. Psychiatry 15(11):1028-33
28. Harper DG, Stopa EG, McKee AC, et al. 2001. Differential circadian rhythm disturbances in men with Alzheimer's disease and frontotemporal degeneration. Arch. Gen. Psychiatry 58:353-60
29. Bliwise DL, Rye DB, Dihenia B, et al. 2002. Greater daytime sleepiness in subcortical stroke relative to Parkinson's disease and Alzheimer's disease. J. Geriatr. Psychiatry Neurol. 15(2):61-67
30. Cohen-Mansfield J, Werner P, Freedman L. 1990. Screaming in nursing home residents. J. Am. Geriatr. Soc. 38(7):785-92
31. Cohen-Mansfield J, Werner P, Freedman L. 1995. Sleep and agitation in agitated nursing home residents: an observational study. Sleep 18(8):674-80
32. Gehrman P, Marler M, Martin JL, et al. 2004. The timing of activity rhythms in patients with dementia is related to survival. J. Gerontol. A Biol. Sci. Med. Sci. 59(10):1050-55
33. Bliwise DL. 1994. What is sundowning? J. Am. Geriatr. Soc. 42:1009-11
34. Evans LK. 1987. Sundown syndrome in institutionalized elderly. J. Am. Geriatr. Soc. 35:101-8
35. Ancoli-Israel S, Gehrman P, Martin JL, et al. 2003. Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer's disease patients. Behav. Sleep Med. 1:22-36
36. Van Gelder RN. 2004. Blue light and the circadian clock. Br. J. Ophthalmol. 88:1353
37. Turek FW. 1004. Circadian rhythms: from the bench to the bedside and falling sleep. Sleep 27(8):1600-2
38. Swaab DF, Fliers E, Partiman TS. 1985. The suprachiasmatic nucleus of the human brain in relation to sex, age, and senile dementia. Brain Res. 342:37-44
39. Stopa EG, Volicer L, Kuo-Leblane V, et al. 1999. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J. Neuropathol. Exp. Neurol. 58:29-39
40. Huitron-Resendiz S, Sanchez-Alvarez M, Gallegos R, et al. 2002. Age-independent and age-related deficits in visuospatial learning, sleep-wake states, thermoregulation and motor activity in PDAPP mice. Brain Res. 928:126-37
41. Huitron-Resendiz S, Sanchez-Alvarez M, Criado JR. 2005. Sleep-wake states in transgenic mouse models overexpressing the human beta-amyloid precursor protein. Am. J. Alzheimer's Dis. Other Demen. 20(2):87-90
42. Vloeberghs E, Van Dam D, Engelborghs S, et al. 2004. Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances. Eur. J. Neurosci. 20(10):2757-66
43. Pollak CP, Perlick D, Linsner JP, et al. 1990 Sleep problems in the community elderly as predictors of death and nursing home placement. J. Community Health 15:134-35
44. Pollak CP, Perlick D. 1991. Sleep problems and institutionalization of the elderly. J. Geriatr. Psychiatry Neurol. 4:204-10
45. Mace NL, Rabins PV. 1993. The 36-Hour Day: A Family Guide to Caring for Persons with Alzheimer Disease, Related Dementing Illnesses, and Memory Loss in Later Life. Baltimore, MD: Johns Hopkins Univ. Press
46. Forbes D, Morgan DG, Bangma J, et al. 2005. Light therapy for managing sleep, behaviour, and mood disturbances in dementia. In The Cochrane Library, Issue 2. Oxford Update Software. http://cochrane.bireme.br/cochrane/show.php, accessed 5/12/05
47. Kim P, Louis C, Muralee S, et al. 2005. Sundowning syndrome in the older patient. Clin. Geriatr. 13(4):32-36
48. Shaw SH, Curson H, Coquelin JP. 1992. A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients. J. Int. Med. Res. 20:150-61;
49. erratum, J. Int. Med Res. 20:494
50. Shelton PS, Hocking LB. 1997. Zolpidem for dementia-related insomnia and nighttime wandering. Ann. Pharmacother. 31:319-22
51. Daniele A, Albanese A, Gainotti G, et al. 1997. Zolpidem in Parkinson's disease. Lancet 349:1222-23
52. Wang PS, Bohn RL, Glynn RJ, et al. 2001. Zolpidem use and hip fractures in older people. J. Am. Geriatr. Soc. 49:1685-90
53. Hoyler CL, Tekell JL, Silva JA. 1996. Zolpidem-induced agitation and disorganization. Gen. Hosp. Psychiatry 18(6):452-53
54. Stoppe G, Sandholzer H, Staedt J, et al. 1995. Sleep disturbances in the demented elderly: treatment in ambulatory care. Sleep 18(10):844-88
55. Tariot PN. 2003. Pharmacological treatment of severe dementia. In Alzheimer's Disease and Related Disorders Research, ed. K Iqbal, B Winblad, pp. 653-61. Bucharest, Romania: "Ana Asian" Int. Acad. Aging
56. Ruth S, Straand J, Nygaard HA, et al. 2004. Effect of antipsychotic withdrawal on behavior and sleep/wake activity in nursing home residents with dementia: a randomized placebo-controlled, double-blinded study. The Bergen District Nursing Home Study. J. Am. Geriatr. Soc. 52(10):1737-43
57. Meguro K, Meguro M, Tanaka Y, et al. 2004. Risperidone is effective for wandering and disturbed sleep/wake patterns in Alzheimer's disease. J. Geriatr. Psychiatry Neurol. 17(2):61-67
58. Falsetti AE. 2000. Risperidone for control of agitation in dementia patients. Am. J. Health Syst. Pharm. 57(9):862-70
59. Monti JM, Cardinali DP. 2000. A critical assessment of the melatonin effect on sleep in humans. Biol. Signals Recept. 9(60):328-39
60. Uchida K, Okamoto N, Ohara K, et al. 1996. Daily rhythm of serum melatonin in patients with dementia of the degenerative type. Brain Res. 717:154-59
61. Dori D, Casale F, Solerte SB, et al. 1994. Chrono-neuroendocrinological aspects of physiological aging and senile dementia. Chronobiologia 21:121-26
62. Mishima K, Tozawa T, Satoh K, et al. 1999. Melatonin secretion rhythm disorders in patients with senile dementia and disturbed sleep-waking. Biol. Psychiatry 45:417-21
63. Balan S, Leibovitz A, Zila SO, et al. 2003. The relation between the clinical subtypes of delirium and the urinary level of 6-SMT. J. Neuropsychiatry Clin. Neurosci. 15:363-66
64. Shigeta H, Yasui A, Nimura Y, et al. 2001. Postoperative delirium and melatonin levels in elderly patients. Am. J. Surg. 182:449-54
65. Ohashi Y, Okamoto N, Uchida K, et al. 1999. Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer's type. Biol. Psychiatry 45:1646-52
66. Olde Rikker MG, Rigaud AS. 2001. Melatonin in elderly patients with insomnia. A systematic review. Z. Gerontol. Geriatr. 34(6):491-97
67. Cardinali DP, Brusco LI, Liberczuk C, et al. 2002. The use of melatonin in Alzheimer's disease. Neuroendocrinology Lett 23(Suppl. 1):20-23
68. Skjerve A, Nygaard HA. 2000. Improvement in sundowning in dementia with Lewy bodies after treatment with donepezil. Int. J. Geriatr. Psychiatry 15(12):1147-51
69. Asayama K, Yamadera H, Ito T, et al. 2003. Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. Nihon Ika Daigaku Zasshi 70(4):334-41
70. Singer C, Tractenberg RE, Kaye J, et al. 2003. Alzheimer's Disease Cooperative Study. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep 26(7):893-901
71. Yorston GA, Gray R. 2000. Hypnopompic hallucinations with donepezil. J. Psychopharmacol. 14:303-4
72. Ross JS, Shua-Haim JR. 1998. Aricept-induced nightmares in Alzheimer's disease: 2 case reports. J. Am. Geriatr. Soc. 46:119-20
73. Rogers SL, Doody RS, Mohs RC, et al. 1998. Donepezil improves cognition and global function in Alzheimer's disease: a 15 week, double-blind, placebo-controlled study. Donepezil Study Group. Arch. Intern. Med. 158:1021-31
74. Markowitz JS, Gutterman EM, Lilienfeld S, et al. 2003. Sleep-related outcomes in persons with mild to moderate Alzheimer's disease in a placebo-controlled trial of galantamine. Sleep 26:602-6
75. McKeith K, Del Ser T, Spano P, et al. 2000. Efficacy of rivastigmine in dementia with Lewy bodies: a randomized, double-blinded, placebo-controlled international study. Lancet 356:2031-36
76. Stahl SM, Markowitz JS, Gutterman EM, et al. 2003. Co-use of donepezil and hypnotics among Alzheimer's disease patients living in the community. J. Clin. Psychiatry 64:466-72
77. Jackson S, Ham RJ, Wilkinson D. 2004. The safety and tolerability of donepezil in patients with Alzheimer's disease. Br. J. Clin. Pharmacol. 58(Suppl. 1):1-8
78. Mizuno S, Kameda A, Inagaki T, et al. 2004. Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep. Psychiatry Clin. Neurosci. 58(6):660-65
79. MacLean LE, Collins CC, Byrne EJ. 2001. Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep. Int. Psychogeriatr. 13:277-88
80. Reading PJ, Luce AK, McKeith IG. 2001. Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open label trial. Mov. Disord. 16:1171-74
81. Stahl SM, Markowitz JS, Papadopoulos G, et al. 2004. Examination of night-time sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer's disease. Curr. Med. Res. Opin. 20(4):517-24
82. Markowitz JS, Gutterman EM, Lilienfeld S, et al. 2003. Sleep-related outcomes in persons with mild to moderate Alzheimer disease in a placebo-controlled trial of galantamine. Sleep 26(5):602-6
83. Reisberg B, Doody R, Stoffler A, et al. 2003. Memantine in moderate-to-severe Alzheimer's disease. The Memantine Study Group. N. Eng. J. Med. 348:1333-41